Join our panel that includes an industry attorney and scientist, who will address legal standards, today’s regulatory environment, and the lawsuit risks and liabilities marketers face if claims are not adequately substantiated. The panel will also include an FTC representative, who will provide the agency’s perspective, updates on recent enforcement actions, and a discussion of the level of substantiation respondents in those actions possessed or did not possess.

The member reception is a unique opportunity to network with colleagues and discuss the latest developments in the herbal industry.

The AHPA-ABC-AHP 2020 HerbWalk at Expo West features a renowned faculty of herbalists who will lead participants through the grounds of the Fullerton Arboretum's 26-acre botanical garden. Herbalists will instruct attendees about the collection of plant species from around the globe and the culinary, medicinal and traditional uses.

This AHPA webinar will review recent changes to CA Prop 65 and how other provisions of this state law apply to the legal cannabis industry, including marketers of hemp-derived CBD products who are in commerce in the state of California.

This webinar is designed to help businesses in the dietary supplement industry understand the elements of current Good Manufacturing Practice (cGMP) regulations (21 CFR 111) that have been the primary focus of FDA inspections. This knowledge will assist businesses in better allocating and directing their compliance resources.

This webinar provides an overview of dietary supplement current good manufacturing (cGMP) requirements for hemp-CBD products. Legal and industry experts provide strategies and resources to comply and document compliance with  federal manufacturing requirements designed to ensure supplement product quality and safety.

Due to overwhelming demand, AHPA is presenting a second, expanded Hemp-CBD Supplement Congress in Portland, OR to provide companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market.

Recorded October 29, 2019, this webinar offers expert insights into the nutrition labeling requirements for foods and dietary supplements are scheduled to take effect January 1, 2020 for manufacturers with $10 million or more in annual sales and January 1, 2021 for smaller manufacturers.

Dr. Rick Kingston, an industry expert with more than 35-years of experience, presents on serious adverse event report (SAER) data and observations. Ashish Talati, a partner with Amin Talati & Wasserman and one of the industry’s foremost experts on FDA regulatory matters, joins Dr. Kingston to review dietary supplement legal and regulatory SAER obligations. In addition, AHPA Chief Information Officer Dr. Merle Zimmermann presents an overview of recent FDA recall data.

Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.